|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | ANTICOAGULANT:TYPES AND ITS DRUG THERAPY |
| Authors Name: | Prem Dhaigude , Samiksha.B.Dadas , Sneha.S.Narute , Sonali.G.Sankpal |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_211581
|
| Published Paper Id: | IJNRD2312425 |
| Published In: | Volume 8 Issue 12, December-2023 |
| DOI: | |
| Abstract: | Historically, utmost cases who needed parenteral anticoagulation entered heparin, whereas those cases taking oral anticoagulation entered warfarin. Due to the narrow remedial indicator and need for frequent laboratory monitoring associated with warfarin, there has been a desire to develop newer, more effective anticoagulants. Accordingly, in recent times numerous new anticoagulants have been developed. The exigency croaker May launch anticoagulation remedy in the short term (e.g. heparin) for a case being admitted, or may start a new anticoagulation for a case being discharged. also, a case on a new anticoagulant may present to the exigency department due to a hemorrhagic complication. Accordingly, the exigency croaker should be familiar with the newer and aged anticoagulants. This review emphasizes the suggestion, medium of action, adverse goods, and implicit reversal strategies for colorful anticoagulants that the exigency croakeR will probably encounter Anticoagulants remain the primary strategy for the forestallment and treatment of thrombosis. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and employed considerably with direct thrombin impediments generally reserved for cases with complications or those taking intervention. new oral anticoagulants have surfaced from clinical development and are anticipated to replace aged agents with their ease of use and more favorable pharmacodynamic biographies. Hemorrhage is the main concerning adverse event with all anticoagulants. With their ubiquitous use, it becomes important for clinicians to have a sound understanding of anticoagulant pharmacology, dosing, and toxin. |
| Keywords: | Anticoagulant,Warfarin,Heparin, ,molecular weight warfarin. |
| Cite Article: | "ANTICOAGULANT:TYPES AND ITS DRUG THERAPY", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 12, page no.e270-e281, December-2023, Available :http://www.ijnrd.org/papers/IJNRD2312425.pdf |
| Downloads: | 000118788 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2312425 Registration ID: 211581 Published In: Volume 8 Issue 12, December-2023 DOI (Digital Object Identifier): Page No: e270-e281 Country: Pune, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2312425 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2312425 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn